4/A

FORM 4/A SUBMISSION

Company: Lineage Cell Therapeutics, Inc.
Filed: April 16, 2009
Period of Report: December 31, 2008
Accession Number: 0001209191-09-021815

View Document ↗ View on SEC.gov ↗